CRISPR Therapeutics AG (CRSP)
50.76
+4.37
(+9.42%)
USD |
NASDAQ |
Nov 01, 16:00
50.80
+0.04
(+0.08%)
After-Hours: 20:00
CRISPR Therapeutics 1 Year Total Returns (Daily): 16.02% for Nov. 1, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 01, 2024 | 16.02% |
October 31, 2024 | 19.16% |
October 30, 2024 | 23.12% |
October 29, 2024 | 26.33% |
October 28, 2024 | 28.32% |
October 25, 2024 | 20.88% |
October 24, 2024 | 15.51% |
October 23, 2024 | 14.71% |
October 22, 2024 | 24.39% |
October 21, 2024 | 25.61% |
October 18, 2024 | 21.00% |
October 17, 2024 | 10.60% |
October 16, 2024 | 9.35% |
October 15, 2024 | 8.44% |
October 14, 2024 | 7.93% |
October 11, 2024 | 4.74% |
October 10, 2024 | 3.54% |
October 09, 2024 | 6.80% |
October 08, 2024 | 4.97% |
October 07, 2024 | 5.64% |
October 04, 2024 | 9.01% |
October 03, 2024 | 4.56% |
October 02, 2024 | 7.78% |
October 01, 2024 | 0.42% |
September 30, 2024 | 3.50% |
Date | Value |
---|---|
September 27, 2024 | 0.40% |
September 26, 2024 | 0.82% |
September 25, 2024 | 0.13% |
September 24, 2024 | 2.86% |
September 23, 2024 | 2.75% |
September 20, 2024 | 3.48% |
September 19, 2024 | 4.37% |
September 18, 2024 | 4.09% |
September 17, 2024 | -1.40% |
September 16, 2024 | -5.61% |
September 13, 2024 | -0.85% |
September 12, 2024 | -8.89% |
September 11, 2024 | -11.02% |
September 10, 2024 | -8.71% |
September 09, 2024 | -10.15% |
September 06, 2024 | -12.66% |
September 05, 2024 | -9.97% |
September 04, 2024 | -10.88% |
September 03, 2024 | -9.91% |
August 30, 2024 | -5.54% |
August 29, 2024 | -5.97% |
August 28, 2024 | -4.96% |
August 27, 2024 | -2.92% |
August 26, 2024 | -1.05% |
August 23, 2024 | -3.58% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-68.03%
Minimum
Jan 24 2022
287.7%
Maximum
Mar 16 2021
25.22%
Average
7.83%
Median
1 Year Total Returns (Daily) Benchmarks
Vertex Pharmaceuticals Inc | 27.56% |
AC Immune SA | 1.69% |
Addex Therapeutics Ltd | 62.12% |
NLS Pharmaceutics Ltd | -87.28% |
Molecular Partners AG | 67.67% |